These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 38828714)

  • 21. Potential clinical utility of multiple system atrophy biomarkers.
    Jellinger KA
    Expert Rev Neurother; 2017 Dec; 17(12):1189-1208. PubMed ID: 29023182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple system atrophy: an update and emerging directions of biomarkers and clinical trials.
    Liu M; Wang Z; Shang H
    J Neurol; 2024 May; 271(5):2324-2344. PubMed ID: 38483626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current experimental disease-modifying therapeutics for multiple system atrophy.
    Lemos M; Wenning GK; Stefanova N
    J Neural Transm (Vienna); 2021 Oct; 128(10):1529-1543. PubMed ID: 34398313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phosphorylated α-synuclein and phosphorylated tau-protein in sural nerves may contribute to differentiate Parkinson's disease from multiple system atrophy and progressive supranuclear paralysis.
    Rong Z; Shen F; Wang Y; Sun L; Wu J; Zhang H; Yuan Y; Jiang W; Li X; Ji P; Zhang K
    Neurosci Lett; 2021 Jun; 756():135964. PubMed ID: 34022266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phosphorylated α-synuclein in skin Schwann cells: a new biomarker for multiple system atrophy.
    Donadio V; Incensi A; Rizzo G; Westermark GT; Devigili G; De Micco R; Tessitore A; Nyholm D; Parisini S; Nyman D; Tedeschi G; Eleopra R; Ingelsson M; Liguori R
    Brain; 2023 Mar; 146(3):1065-1074. PubMed ID: 35552610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple system atrophy of the cerebellar type: clinical state of the art.
    Lin DJ; Hermann KL; Schmahmann JD
    Mov Disord; 2014 Mar; 29(3):294-304. PubMed ID: 24615754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Animal modeling an oligodendrogliopathy--multiple system atrophy.
    Bleasel JM; Halliday GM; Kim WS
    Acta Neuropathol Commun; 2016 Feb; 4():12. PubMed ID: 26860328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Translational therapies for multiple system atrophy: Bottlenecks and future directions.
    Stefanova N
    Auton Neurosci; 2018 May; 211():7-14. PubMed ID: 29017831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Review: Multiple system atrophy: emerging targets for interventional therapies.
    Stefanova N; Wenning GK
    Neuropathol Appl Neurobiol; 2016 Feb; 42(1):20-32. PubMed ID: 26785838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alpha-Synuclein Oligomers and Neurofilament Light Chain Predict Phenoconversion of Pure Autonomic Failure.
    Singer W; Schmeichel AM; Shahnawaz M; Schmelzer JD; Sletten DM; Gehrking TL; Gehrking JA; Olson AD; Suarez MD; Misra PP; Soto C; Low PA
    Ann Neurol; 2021 Jun; 89(6):1212-1220. PubMed ID: 33881777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple system atrophy: an update.
    Stefanova N; Bücke P; Duerr S; Wenning GK
    Lancet Neurol; 2009 Dec; 8(12):1172-8. PubMed ID: 19909915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Skin Biopsy May Help to Distinguish Multiple System Atrophy-Parkinsonism from Parkinson's Disease With Orthostatic Hypotension.
    Donadio V; Incensi A; Rizzo G; De Micco R; Tessitore A; Devigili G; Del Sorbo F; Bonvegna S; Infante R; Magnani M; Zenesini C; Vignatelli L; Cilia R; Eleopra R; Tedeschi G; Liguori R
    Mov Disord; 2020 Sep; 35(9):1649-1657. PubMed ID: 32557839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human alpha-synuclein overexpressing MBP29 mice mimic functional and structural hallmarks of the cerebellar subtype of multiple system atrophy.
    Mészáros L; Riemenschneider MJ; Gassner H; Marxreiter F; von Hörsten S; Hoffmann A; Winkler J
    Acta Neuropathol Commun; 2021 Apr; 9(1):68. PubMed ID: 33853667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple system atrophy.
    Wenning GK; Krismer F
    Handb Clin Neurol; 2013; 117():229-41. PubMed ID: 24095129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of 123I-MIBG scintigraphy and phosphorylated α-synuclein skin deposits in synucleinopathies.
    Giannoccaro MP; Donadio V; Giannini G; Devigili G; Rizzo G; Incensi A; Cason E; Calandra-Buonaura G; Eleopra R; Cortelli P; Liguori R
    Parkinsonism Relat Disord; 2020 Dec; 81():48-53. PubMed ID: 33049589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuropathology and molecular diagnosis of Synucleinopathies.
    Koga S; Sekiya H; Kondru N; Ross OA; Dickson DW
    Mol Neurodegener; 2021 Dec; 16(1):83. PubMed ID: 34922583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Models of multiple system atrophy.
    Fellner L; Wenning GK; Stefanova N
    Curr Top Behav Neurosci; 2015; 22():369-93. PubMed ID: 24338664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Review on the Clinical Diagnosis of Multiple System Atrophy.
    Stankovic I; Fanciulli A; Sidoroff V; Wenning GK
    Cerebellum; 2023 Oct; 22(5):825-839. PubMed ID: 35986227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prodegenerative IκBα expression in oligodendroglial α-synuclein models of multiple system atrophy.
    Kragh CL; Gysbers AM; Rockenstein E; Murphy K; Halliday GM; Masliah E; Jensen PH
    Neurobiol Dis; 2014 Mar; 63():171-83. PubMed ID: 24361600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosis of multiple system atrophy.
    Palma JA; Norcliffe-Kaufmann L; Kaufmann H
    Auton Neurosci; 2018 May; 211():15-25. PubMed ID: 29111419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.